Literature DB >> 6125074

Effect of betaxolol on heart rate at rest and during exercise.

H Kesteloot, A Missotten, R Coupez-Lopinot, R Sluyts.   

Abstract

Betaxolol, a new beta-receptor blocking drug administered as a single dosage of 40 mg given orally, causes a maximal reduction of heart rate at rest of 30%, during a submaximal exercise of 28% and at rest after exercise of 33%. The reduction in heart rate is still highly significant 48 hours after administration at rest, during exercise as well after administration. A smaller but still significant reduction in heart rate was found after the oral administration of 20 mg of betaxolol. Betaxolol appears to be more effective than a single oral dose of 160 mg of long-acting propranolol. No significant differences were found between 9 submaximal exercise tests performed within a period of 50 hours in normal subjects.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6125074

Source DB:  PubMed          Journal:  Acta Cardiol        ISSN: 0001-5385            Impact factor:   1.718


  1 in total

Review 1.  Betaxolol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension.

Authors:  R Beresford; R C Heel
Journal:  Drugs       Date:  1986-01       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.